NCT00051818View on ClinicalTrials.gov

Immune and Viral Outcomes of HIV-1 Therapy Interruption

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

May 31, 2003

Study Completion Date

July 31, 2003

Conditions
HIV Infections
Interventions
BEHAVIORAL

Treatment interruption/reinitiation schedule

Trial Locations (1)

19104

The Wistar Institute, Philadelphia

All Listed Sponsors
lead

The Wistar Institute

OTHER

NCT00051818 - Immune and Viral Outcomes of HIV-1 Therapy Interruption | Biotech Hunter | Biotech Hunter